Medibank Hires Frontier Advisors for Investment Advice
Medibank Group's net investment income fell 13.9% to $178.9 million in FY26 as it expands its investment advisory arrangements.
Updated on Nov. 5, 2026 in Healthcare
Live Poll
Do you trust large health insurers to manage their investments in your interest?
Medibank Group has awarded Frontier Advisors a mandate covering asset allocation and external manager selection and monitoring. The move follows a $28.9 million, or 13.9%, decline in the group's net investment income to $178.9 million in FY26.
Why it matters
Investment income is a material contributor to the earnings of the ASX-listed health insurer, so changes in its portfolio performance draw attention from investors. The decline was driven by lower equity income and a lower average RBA cash rate.
Medibank's net investment income fell $28.9 million to $178.9 million in FY26, with growth and defensive portfolio income each down $7 million. Its $3.4 billion portfolio includes $3.1 billion held for the health fund, and the group expects income to benefit in 2027 from balance growth and a higher average RBA cash rate.
The players
Medibank Group
Medibank Group is an ASX-listed Australian private health insurer whose investment income is subject to oversight by the Australian Prudential Regulation Authority.
Frontier Advisors
Frontier Advisors is an Australian investment consultancy that provides asset allocation and manager selection services to institutional investors, drawing here on its Liability Driven Investing team.
The details
Medibank's growth portfolio income declined due to lower returns from Australian and international equities, partly offset by better property and infrastructure performance. Defensive portfolio income fell after a $7.5 million drop in interest income from the lower average RBA cash rate and a $2.7 million cost from widening credit spreads.
Timeline
FY26: Net investment income declined to $178.9 million.
30 June 2026: Investment portfolio valued at $3.4 billion.
2027: Medibank expects net investment income to benefit from balance growth and a higher average RBA cash rate.
Roadmap
Medibank's income decline reflects the sensitivity of defensive portfolio returns to the RBA cash rate, which fell over the period and reduced interest income. The group's expectation of a benefit from a higher average RBA cash rate in 2027 ties its earnings outlook directly to future monetary policy.
For policyholders, the story has no direct effect on premiums or cover based on the extraction. For investors, Medibank's guidance that income should benefit in 2027 from balance growth and higher rates is the main signal to track.
The takeaway
Investment income can move sharply with interest rates and equity markets, so health insurers' earnings are not fully determined by premiums alone. Watching the RBA cash rate and portfolio disclosures gives a clearer picture of an insurer's underlying performance.
Further reading
For related coverage, browse the Healthcare section for more on the sector's finances in Australia.
Source note: This article includes information reported by Financial Standard.
Live Poll
Do you trust large health insurers to manage their investments in your interest?
